<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>p18(Ink4c) functions as a dedicated inhibitor of cyclin-D-dependent kinases </plain></SENT>
<SENT sid="1" pm="."><plain>Loss of Ink4c predisposes mice to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development and, in a dose-dependent manner, complements the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-promoting effects of various oncogenes </plain></SENT>
<SENT sid="2" pm="."><plain>We have now addressed whether Ink4c loss impacts B-cell <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> development in the Emu-Myc transgenic mouse, a model of human Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Loss of one or both alleles did not influence the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in Emu-Myc transgenics, and did not appreciably affect Myc's proliferative or apoptotic responses in precancerous B cells </plain></SENT>
<SENT sid="4" pm="."><plain>Nevertheless, Ink4c loss modulated the effects of Myc-induced transformation by decreasing the frequency of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">Arf</z:e> loss, an ordinarily common event in Emu-Myc-induced <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
</text></document>